moderna announces instead of rolling submission to health canada for mrna vaccine against covid-19
moderna announces instead of rolling submission to health canada for mrna vaccine against covid-19
we are pleased with the interactions with the canadian regulatory authorities and we appreciate their guidance and confidence in moderna to pursue a rolling submission in canada for our covid-19 vaccine candidate, mrna-1273, said stéphane bancel, modernas chief executive officer.